© 2022 MJH Life Sciences™ and Contemporary Pediatrics. All rights reserved.
Respiratory
Do we take respiratory syncytial virus seriously enough?
January 11, 2022
What the HCP community can do to change our approach
Comparing LABA plus inhaled corticosteroids to inhaled corticosteroids only for treating prematurity-associated lung disease
December 15, 2021
Decreased lung function may be a result of a preterm delivery. Does treatment with long-acting β2 agonists (LABA) plus inhaled corticosteroids perform better than just inhaled corticosteroids to improve lung function in affected children?
Examining the efficacy of dupilumab for uncontrolled asthma in kids 6-11
December 14, 2021
Used to treat asthma in adolescents and adults, a clinical trial examines whether it would be effective in treating uncontrolled asthma in younger children.
Utilizing peer leaders to improve asthma management in teens living in urban areas
December 09, 2021
In spite of the availability of effective treatments, asthma is not always well controlled among teenagers. An investigation examines whether using peers to helm education efforts can lead to improved outcomes.
Examining the seasonal shift of RSV
December 07, 2021
The jury is out on whether testing or exposure better explains the unseasonable surge of respiratory syncytial virus.
Priority review of VAXNEUVANCE™ for kids 6 weeks to 17 years accepted by FDA
December 02, 2021
The US Food and Drug Administration has accepted a Priority Review of the pneumococcal 15-valent conjugate vaccine VAXNEUVANCE™ in children aged 17 years and younger.
Study into long-term outcomes of COVID-19 in kids launched
November 18, 2021
The National Institutes of Health announced the launch of a long-term study into the long ranging outcomes of recovering from COVID-19 in children, adolescents, and young adults.
Did FDA safety communications alter opioid cough medication prescription behaviors?
November 16, 2021
An investigation examines whether safety communications from the US Food and Drug Administration (FDA) in 2017 and 2018 led to reductions in the prescription of cough and cold medications with codeine and hydrocodone.
Is it COVID-19 or CAP? A look at diagnostic decisions and treatments for 2021-2022
October 18, 2021
Between the subtle differences between viral and bacterial pneumonia and the demands or beliefs of certain parents can make an accurate diagnosis of community-acquired pneumonia (CAP) more difficult.